HCG Manavata Cancer Centre is Maharashtra’s first NABH-accredited cancer hospital, treating over 75,000 patients yearly. Immunotherapy there may cost around A$11,000–A$21,000. The centre is a regional pioneer in Nuclear Medicine and advanced radiotherapy like TomoTherapy-H and Versa HD. Dr Shaunak Valame, a medical oncologist specialising in immunotherapy and targeted therapies, has presented research at ASCO Gastrointestinal Cancer Symposium. The Manavata Clinical Research Institute is audited by the US-FDA, offering access to clinical trials.